Medical Writers News Hubb
Advertisement Banner
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home News

Avail Medsystems plans to roll out third-party software integration

admin by admin
October 21, 2022
in News


Avail Medsystems CEO Daniel Hawkins [Photo courtesy of Avail Medsystems]

Avail Medsystems is testing a third-party software integration that it plans to launch in the coming months.

Avail executives said they hope it will be the first of many partnerships with medical technology developers of software or algorithms that could be useful in the operating room.

Avail CEO Daniel Hawkins expects to launch the software integration in the first quarter of 2023, he told Medical Design & Outsourcing after a panel discussion at DeviceTalks West in Santa Clara, California. He declined to name his company’s partner, but offered some details as the product goes through UI and customer experience testing.

“A remote user can pull up that software and optimize the workflow in a specialty category that really benefits from workflow enhancement,” he said. “The beautiful part is that same workflow enhancement capability can be put into other clinical specialties to optimize new product adoption workflows.”

Avail’s device has cameras, a proprietary audio system, inputs, a flat panel display screen and cloud connectively to let surgeons confer in real-time with a global network of experts who can see and hear what’s happening in the operating room.

RELATED: How Avail Medsystems seeks to create a connected OR experience

“Workflow optimization software is only useful if the people in the room can actually see the workflow. That’s what this is, because of our flat panel in the room. … This capability is leveraging from a remote perspective an ability to display what you choose on the screen to optimize workflow in complicated procedures,” Hawkins said.

Avail designed its system with the ability to add computing power to support additional software that it plans to develop, as well as third-party offerings. That could include workflow software, Software as a Medical Device (SaMD) products without any hardware and software that partners with smart devices.

Speaking to an audience of medtech professionals including designers and engineers, Hawkins laid out the plan to use Avail’s network of devices as platforms for operating room software.

“We’re providing that conduit for what is a budding industry of third-party clinically-driven or process-flow-driven software … to ride into a procedure room without the obligation of worrying about how they’re going to get input, how they’re going to get access, and how they’ll display output,” Hawkins said. “So you should be thinking about this, if you will, as a digital hub.”

Chief Technology Officer James Domine — previously of TiVo, Ericsson and Microsoft — said the system will serve as a host for the “huge explosion” of medtech software in need of a device with a presence in the operating room.

“No longer is it just the algorithms we write in traditional computer programs,” he said. Now it’s moved on into and evolved into machine learning and AI. And your product in that world could be a model. It’s entirely virtual. …  I’m really excited about this because there’s this world of opportunities where people are doing amazingly great work, but what they’re missing is a host.”

 



Source link

Previous Post

Beckman Coulter Life Sciences presenting at ASHG

Next Post

Researchers identify a natural defense mechanism that protects cells from Pseudomonas infection

Next Post

Researchers identify a natural defense mechanism that protects cells from Pseudomonas infection

Recommended

Researchers think a wireless brain implant could remove cancer

3 months ago

Single-cell RNA sequencing reveals dynamic immune landscape during the early stages of bubonic plague

6 months ago

Why Medtronic’s paying up to $1B for Affera’s cardiac ablation tech

4 months ago

Novel peanut-specific human IgE monoclonal antibodies may uncover new therapeutic targets for peanut allergy

6 months ago

Study shows angiotensin-converting enzyme 2 decoy protein as a promising anti-SARS-CoV-2 agent

3 months ago

Can Google searches forecast medical device demand?

2 months ago
Medical-Writers-(-white-)

© Medical Writers News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Papers
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Papers
  • Contact

© 2022 Medical Writers News Hubb All rights reserved.